| The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients J Hallin, LD Engstrom, L Hargis, A Calinisan, R Aranda, DM Briere, ... Cancer discovery 10 (1), 54-71, 2020 | 978 | 2020 |
| Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer KL Bryant, CA Stalnecker, D Zeitouni, JE Klomp, S Peng, AP Tikunov, ... Nature medicine 25 (4), 628-640, 2019 | 562 | 2019 |
| Combined BRAF and MEK inhibition with dabrafenib and trametinib in BRAF V600–mutant colorectal cancer RB Corcoran, CE Atreya, GS Falchook, EL Kwak, DP Ryan, JC Bendell, ... Journal of clinical oncology 33 (34), 4023, 2015 | 533 | 2015 |
| Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis M Pierobon, CL Frankenfeld Breast cancer research and treatment 137, 307-314, 2013 | 415 | 2013 |
| A portrait of tissue phosphoprotein stability in the clinical tissue procurement process V Espina, KH Edmiston, M Heiby, M Pierobon, M Sciro, B Merritt, S Banks, ... Molecular & cellular proteomics 7 (10), 1998-2018, 2008 | 244 | 2008 |
| Mechanism of cell adaptation: when and how do cancer cells develop chemoresistance? V Fodale, M Pierobon, L Liotta, E Petricoin The Cancer Journal 17 (2), 89-95, 2011 | 230 | 2011 |
| Long-term ERK inhibition in KRAS-mutant pancreatic cancer is associated with MYC degradation and senescence-like growth suppression TK Hayes, NF Neel, C Hu, P Gautam, M Chenard, B Long, M Aziz, ... Cancer cell 29 (1), 75-89, 2016 | 229 | 2016 |
| Laser capture microdissection technology V Espina, M Heiby, M Pierobon, LA Liotta Expert review of molecular diagnostics 7 (5), 647-657, 2007 | 216 | 2007 |
| The KRAS (G12C) inhibitor MRTX849 provides insight toward therapeutic susceptibility of KRAS-mutant cancers in mouse models and patients. Cancer Discov. 2020; 10: 54–71. doi … J Hallin, LD Engstrom, L Hargis, A Calinisan, R Aranda, DM Briere, ... Nat Can 1 (1), 25-7, 2020 | 185 | 2020 |
| Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer GA Hobbs, NM Baker, AM Miermont, RD Thurman, M Pierobon, TH Tran, ... Cancer discovery 10 (1), 104-123, 2020 | 153 | 2020 |
| Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy JD Wulfkuhle, R Speer, M Pierobon, J Laird, V Espina, J Deng, ... Journal of proteome research 7 (4), 1508-1517, 2008 | 152 | 2008 |
| Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping JD Wulfkuhle, D Berg, C Wolff, R Langer, K Tran, J Illi, V Espina, ... Clinical cancer research 18 (23), 6426-6435, 2012 | 124 | 2012 |
| Lung cancer prognosis before and after recurrence in a population-based setting D Consonni, M Pierobon, MH Gail, M Rubagotti, M Rotunno, A Goldstein, ... Journal of the National Cancer Institute 107 (6), djv059, 2015 | 113 | 2015 |
| Gain-of-Function RHOA Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric Cancer H Zhang, A Schaefer, Y Wang, RG Hodge, DR Blake, JN Diehl, ... Cancer discovery 10 (2), 288-305, 2020 | 108 | 2020 |
| Lessons from the Ebola outbreak: action items for emerging infectious disease preparedness and response KH Jacobsen, AA Aguirre, CL Bailey, AV Baranova, AT Crooks, A Croitoru, ... EcoHealth 13, 200-212, 2016 | 98 | 2016 |
| Reverse-phase protein microarrays: application to biomarker discovery and translational medicine A VanMeter, M Signore, M Pierobon, V Espina, LA Liotta, EF Petricoin Iii Expert review of molecular diagnostics 7 (5), 625-633, 2007 | 92 | 2007 |
| Alcohol consumption and violence among Argentine adolescents M Pierobon, M Barak, S Hazrati, KH Jacobsen Jornal de Pediatria (Versão em Português) 89 (1), 100-107, 2013 | 86 | 2013 |
| Enrichment of PI3K-AKT–mTOR pathway activation in hepatic metastases from breast cancer M Pierobon, C Ramos, S Wong, KA Hodge, J Aldrich, S Byron, ... Clinical Cancer Research 23 (16), 4919-4928, 2017 | 84 | 2017 |
| Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast G Zavagno, P Carcoforo, R Marconato, Z Franchini, G Scalco, P Burelli, ... BMC cancer 5, 1-6, 2005 | 82 | 2005 |
| Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells D Bose, LJ Zimmerman, M Pierobon, E Petricoin, F Tozzi, A Parikh, F Fan, ... British journal of cancer 105 (11), 1759-1767, 2011 | 81 | 2011 |
